Skip to main content
Veterinary Medicines

Flevox 134 mg spot-on solution for medium dogs

Authorised
  • Fipronil

Product identification

Medicine name:
Flevox 134 mg spot-on solution for medium dogs
FLEVOX, 134 mg užlašinamasis tirpalas vidutinio dydžio šunims
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Fipronil
    134.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Cardboard box containing 50 blisters of 1 pipette of 1.34 ml
  • Cardboard box containing 36 blisters of 1 pipette of 1.34 ml
  • Cardboard box containing 30 blisters of 1 pipette of 1.34 ml
  • Cardboard box containing 6 blisters of 1 pipette of 1.34 ml
  • Cardboard box containing 3 blisters of 1 pipette of 1.34 ml
  • Cardboard box containing 1 blister of 1 pipette of 1.34 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/11/2045/007-012
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0355/003
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 23/03/2023
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 8/01/2026